08 Jun 22

EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—June 08, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the completion of enrollment in the LIFT Home Study.

09 May 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—May 9, 2022, 15:00 CET--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announces the first patient enrollment in the HemON Study and first human use of the Company’s ARCIM implantable pulse generator (IPG), designed to stimulate the spinal cord to restore movement and autonomic function for people with spinal cord injury and other conditions that affect mobility.
29 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland — April 29, 2022, 7:00 CET – ONWARD Medical N.V. (Euronext: ONWD) (the Company), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today has convened the 2022 Annual General Meeting of Shareholders (AGM), including the resolutions to be submitted for adoption at the AGM, which will be held in Amsterdam, the Netherlands, on June 10, 2022.
26 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 26, 2022, 7:00 CET– ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces its annual financial and operating results for the year ended December 31, 2021. The Company also provides a business update for Q1 2022.

Upcoming Events

More events are coming soon.